Brain Imaging May Help Predict Psilocybin Response
Higher baseline SV2A binding was associated with greater antidepressant improvement after psilocybin in a 35-participant preprint study. The exploratory finding requires validation, and researchers detected no group-level increase in the PET marker of synaptic density.
Read MoreLatest Articles
VA TMS Access Expands As Programs Grow From Six To Nearly 70
November 17, 2026
Music-Timed TMS Enhances Motor Cortex Responses In Small Preprint Study
November 16, 2026
Psilocin Analogue Clears First Phase 3 Depression Trial
November 16, 2026
Brain Signaling May Explain Psychedelics’ Antidepressant Effects
November 13, 2026
rTMS and tACS Alter Brain Networks in Bipolar II Disorder
November 12, 2026
IPN Market Watch
Across Interventional Psychiatry
Interventional Psychiatry,
Delivered Weekly
Every week, we deliver the latest news, research, and real-world updates from the frontlines of interventional psychiatry.
Reach out for guest article or sponsorship opportunities
Interested in collaborating with us?
Share your details, and let’s explore how we can work together to create meaningful experiences for our audience.
